Literature DB >> 3930494

Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin.

S Kasai, H Arimura, M Nishida, T Suyama.   

Abstract

A plasminogen activator secreted from human kidney cells was highly purified by affinity chromatography on an anti-urokinase IgG-Sepharose column. The purified plasminogen activator was inactive and had a single-chain structure and a Mr of 50,000. It not only did not incorporate diisopropyl fluorophosphate, which reacts with active site serine residue in urokinase, but also did not bind to p-aminobenzamidine-immobilized CH-Sepharose, to which urokinase bind via its side-chain binding pocket present in active center. The plasminogen activator was converted to the active two-chain form with the same Mr by catalytic amounts of plasmin. Its potential enzymatic activity was quenched completely by anti-urokinase IgG, but not by anti-tissue plasminogen activator Ig. These results indicate that the plasminogen activator is an inactive proenzyme form of human urokinase. Therefore, the plasminogen activator was termed single-chain pro-urokinase. The cleavage of single-chain pro-urokinase by plasmin induced conformational change which followed the generation of reactive serine residue at active site, the increase enzyme activity and the reduction of its high affinity for fibrin. These findings suggest that conformational change occurs in both regions responsible for enzyme activity and affinity for fibrin upon activation of single-chain pro-urokinase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930494

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration.

Authors:  Alexander Kapustin; Victoria Stepanova; Natalia Aniol; Douglas B Cines; Alexei Poliakov; Serge Yarovoi; Tatiana Lebedeva; Robin Wait; Grigory Ryzhakov; Yelena Parfyonova; Yaroslav Gursky; Hiromi Yanagisawa; Mikhail Minashkin; Robert Beabealashvilli; Alexander Vorotnikov; Alex Bobik; Vsevolod Tkachuk
Journal:  Biochem J       Date:  2012-04-15       Impact factor: 3.857

2.  Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis.

Authors:  A V Iakhiaev; A Nalian; K Koenig; S Idell
Journal:  Thromb Res       Date:  2007-02-02       Impact factor: 3.944

3.  Human endothelial cell line, ECV304, produces pro-urokinase.

Authors:  K Takahashi; Y Sawasaki
Journal:  In Vitro Cell Dev Biol       Date:  1991-10

4.  Localization of the binding site of tissue-type plasminogen activator to fibrin.

Authors:  A Ichinose; K Takio; K Fujikawa
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

5.  Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation.

Authors:  A Poliakov; V Tkachuk; T Ovchinnikova; N Potapenko; S Bagryantsev; V Stepanova
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

6.  Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.

Authors:  Victoria Stepanova; Padma-Sheela Jayaraman; Sergei V Zaitsev; Tatiana Lebedeva; Khalil Bdeir; Rachael Kershaw; Kelci R Holman; Yelena V Parfyonova; Ekaterina V Semina; Irina B Beloglazova; Vsevolod A Tkachuk; Douglas B Cines
Journal:  J Biol Chem       Date:  2016-05-04       Impact factor: 5.157

7.  Close similarity between cultured human omental mesothelial cells and endothelial cells in cytochemical markers and plasminogen activator production.

Authors:  K Takahashi; J Hata; K Mukai; Y Sawasaki
Journal:  In Vitro Cell Dev Biol       Date:  1991-07

8.  Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase.

Authors:  Anastasia M Makarova; Tatiana V Lebedeva; Taher Nassar; Abd Al-Roof Higazi; Jing Xue; Maria E Carinato; Khalil Bdeir; Douglas B Cines; Victoria Stepanova
Journal:  J Biol Chem       Date:  2011-05-03       Impact factor: 5.157

9.  Inhibition of plasmin by fibrinogen.

Authors:  A A Higazi; M Mayer
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

10.  Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood.

Authors:  D Menzel; M Levi; G Dooijewaard; M Peters; J W ten Cate
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.